Cite
HARVARD Citation
Gasparetto, M. et al. (2022). Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor. Journal of pediatric gastroenterology and nutrition. 74 (4), pp. 484-489. [Online].